SEARCH

SEARCH BY CITATION

Literature Cited

  • 1
    Wang A, Lewus R, Rathore AS. Comparison of different options for harvest of a therapeutic protein product from high cell density yeast fermentation broth. Biotech Bioeng. 2006;94:91-104.
  • 2
    Roush DJ, Lu Y. Advances in primary recovery: centrifugation and membrane technology. Biotechnol Prog. 2008;24:466-495.
  • 3
    Yigzaw Y, Piper R, Tran M, Shukla AA. Exploitation of the adsorptive properties of depth filters for host cell protein removal during monoclonal antibody purification. Biotechnol Prog. 2006;22:288-296.
  • 4
    Haverstock R, Westoby M, Lam Y. CHOP Removal by Depth Filtration Post-Protein A Capture. Paper Presented at: 239th American Chemical Society National Meeting. San Francisco, California; March 2010.
  • 5
    Charlton HR, Relton JM, Slater NKH. Characterization of a generic monoclonal antibody harvesting system for adsorption of DNA by depth filters and various membranes. Bioseparation. 1999;8:281-299.
  • 6
    Van Reis R, Zydney A. Bioprocess membrane technology. J Membr Sci. 2007;297:16-50.
  • 7
    Elvin JG, Couston RG, van der Walle CF. Therapeutic antibodies: market considerations, disease targets, and bioprocessing. Int J Pharm. 2013;440:83-98.
  • 8
    Kelley B. Industrialization of mAb production technology: the bioprocessing industry at a crossroads. mAbs. 2009;1:443-452.
  • 9
    Hacker DL, Nallet S, Wurm FM. Recombinant protein production yields from mammalian cells: past, present, and future. Biopharm Int Suppl. 2008;21:s6-s15.
  • 10
    Iammarino M, Nti-Gyabaah J, Chandler M, Roush D, Goklen K. Impact of cell density and viability on primary clarification of mammalian cell broth. Bioprocess Int. 2007;5:38-50.
  • 11
    Roush DJ, Lu Y. Advances in primary recovery: centrifugation and membrane technology. Biotechnol Prog. 2008;24:466-495.
  • 12
    Westoby M, Chrostowski J, de Vilmorin P, Smelko JP, Romero JK. Fermentation broth properties: enhanced impurity removal and clarification performance. Biotech Bioeng. 2011;108:50-58.
  • 13
    Prashad M, Tarrach K. Cell clarification of bioreactor offloads. Filtration Sep. 2006;43:28-30.
  • 14
    Kempken R, Preissman A, Berthold W. Assessment of a disc stack centrifuge for use in mammalian cell separation. Biotech Bioeng. 1995;46:132-138.
  • 15
    Iammarino M, Nti-Gyabaah J, Chandler M, Roush D, Goklen K. Impact of cell density and viability on primary clarification of mammalian cell broth. Bioprocess Int. 2007;5:38-50.
  • 16
    Farid SS. Process economics of industrial monoclonal antibody manufacture. J Chromatogr B. 2007;848:8-18.
  • 17
    Lim JAC, Patkar A, McDonagh G, Sinclair A, Lucy P. Modeling bioprocess cost: process economic benefits of expression technology based on Pseudomonas fluorescens. BioProcess Int. 2010;8:62-70.
  • 18
    Hove S, Cacace B, Felo M, Chefer K. Development of a Robust Clarification Process for High Density Mammalian Cell Culture Processes. Paper Presented at: Recovery of Biological Products XIV. Lake Tahoe, California; August 2010.
  • 19
    Romero J, Chrostowski J, De Vilmorin PG, Case JY, inventors; Biogen Idec Inc., assignee. Method of Isolating Biomacromolecules Using Low pH and Divalent Cations. World Patent 2008127305 A3; 2008.
  • 20
    Riske F, Schroeder J, Belliveau J, Kang X, Kutzko J, Menona MK. The use of chitosan as a flocculant in mammalian cell culture dramatically improves clarification throughput without adversely impacting monoclonal antibody recovery. J Biotechnol. 2007;128:813-823.
  • 21
    Coffman J, Shpritzer RI, Vicik SM, inventors; Wyeth, assignee. Protein Flocculation Using Salts. World Patent 2007035283 A1; 2007.
  • 22
    Trexler-Schmidt M, Sze-Khoo S, Cothran AR, Thai BQ, Sargis S, Lebreton B, Kelley B, Blank GS. Purification strategies to process 5 g/L titers of monoclonal antibodies. BioPharm Int Suppl. 2009;22:s8-s15.
  • 23
    Lutz H, Blanchard M, Abbott I, Parampalli A, Setiabudi G, Chiruvolu V, Noguchi M. Considerations for scaling-up depth filtration of harvested cell culture fluid. Biopharm Int. 2009;22:58-66.
  • 24
    Hutchinson N, Bingham N, Murrell N, Farid S, Hoare M. Shear stress analysis of mammalian cell suspensions for prediction of industrial centrifugation and its verification. Biotech Bioeng. 2006;95:483-491.
  • 25
    Westoby M, Rogers JK, Haverstock R, Romero J, Pieracci J. Modeling industrial centrifugation of mammalian cell culture using a capillary based scale-down system. Biotech Bioeng. 2011;108:989-998.
  • 26
    Iammarino M, Nti-Gyabaah J, Chandler M, Roush D, Goklen K. Impact of cell density and viability on primary clarification of mammalian cell broth. Bioprocess Int. 2007;5:38-50.
  • 27
    Bracewell DG, Boychyn M, Baldascini H, Storey SA, Bulmer M, More J, Hoare M. Impact of clarification strategy on chromatographic separations: preprocessing of cell homogenates. Biotech Bioeng. 2008;100:941-949.